Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Overcoming NK Cell-Mediated Allograft Rejection By Anti-3 rd Party Central Memory Veto CD8 T Cells through Down-Regulation of the Activating Receptor DNAM-1 on Alloreactive NK Cells

Wei-Hsin Liu, Aloukick Singh, Sandeep Yadav, Esther Bachar Lustig, Yair Reisner

Blood (2024) 144 (Supplement 1): 3401.

https://doi.org/10.1182/blood-2024-203601

Published: 2024

Journal Articles

Allogeneic Veto-CAR CD8 T Cells Enabling Prolonged Graft Survival, Anti-Tumor Specificity, and Low Risk of Graft Versus Host Disease

Wei-Hsin Liu, Anat Globerson Levin, Assaf Lask, Galit Horn, Tova Waks, Bar Nathansohn Levy, Maksim Mamonkin, Zelig Eshhar, Richard E. Champlin, Yair Reisner, Esther Bachar Lustig

Blood (2023) 142 (Supplement 1): 4833.

https://doi.org/10.1182/blood-2023-175033

Published: 2023

Journal Articles

First in Human Study of Anti-Viral Veto Cells Enabling Successful Engraftment without Severe Gvhd in Non-Myeloablative T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

Blood (2022) 140 (Supplement 1): 2120–2122.

https://doi.org/10.1182/blood-2022-159183

Published: 2022

Journal Articles

Towards Safer Allogeneic HSCT in Autoimmunity: Proof of Concept in Diabetes-Prone Mice

Rakefet Sidlik Muskatel, MD, Bar Nathansohn-Levi, PhD, Esther BACHAR Lustig, PhD, Yair Reisner, PhD

Blood (2019) 134 (Supplement_1): 3212.

https://doi.org/10.1182/blood-2019-124905

Published: 2019

Journal Articles

Proof of Concept for Repair of Sickle Cell Disease By Non-Myeloablative MHC Disparate T Cell Depleted HSCT Combined with Donor-Derived Veto Cells

Aloukick Kumar Singh, PhD, Elias Schetzen, PhD, Esther BACHAR Lustig, PhD, Wei-Hsin Liu, M.Sc, Raj Kumar Yadav, PhD, Sandeep Kumar Yadav, PhD, Kathryn McGinnis, M.Sc, Yair Reisner, PhD

Blood (2019) 134 (Supplement_1): 1919.

https://doi.org/10.1182/blood-2019-124594

Published: 2019

Journal Articles

High Levels of Hematopoietic Progenitors in the Fetal Lung Enable Induction of Immune Tolerance and Co-Transplantation of Epithelial Progenitors for Repair of Lung Injury Across MHC Barriers

Carmit Hillel Karniel, MSc, Chava Rosen, MD PhD, Esther Bachar Lustig, PhD, Elias Shezen, PhD, Yair Reisner, PhD

Blood (2016) 128 (22): 1477.

https://doi.org/10.1182/blood.V128.22.1477.1477

Published: 2016

Journal Articles

Next Generation Veto Cells for Non-Myeloablative Haploidentical HSCT: Combining Anti-Viral and Graft Facilitating Activity

Esther Bachar Lustig, PhD, Noga Or Geva, PhD, Assaf Lask, PhD, Rotem Gidron, MD, Sivan Kagan, PhD, Aloukick Kumar Sinqh, PhD, Yair Reisner, PhD

Blood (2016) 128 (22): 3345.

https://doi.org/10.1182/blood.V128.22.3345.3345

Published: 2016

Journal Articles

Towards 'Off-the-Shelf ' Universal Chimeric Antigen Receptor (CAR) T Cells: Mouse Anti-3 rd Party Central Memory CD8 Veto Cells Prolong Functional Engraftment of Allogeneic Genetically Modified T Cells

Noga Or Geva, PhD, Rotem Gidron, MD, Aloukick Kumar Singh, PhD, Rakefet Sidlik Muskatel, MD, Yair Reisner, PhD

Blood (2016) 128 (22): 2171.

https://doi.org/10.1182/blood.V128.22.2171.2171

Published: 2016

Journal Articles

Transplantation of T Cell Depleted Haploidentical HSCT Following Non-Myeloablative (NMA) Conditioning: Combining the Power of Megadose Transplants with Post Transplant Cyclophosphamide (PTCY)

Franco Aversa, MD, Esther BacharLustig, PhD, Lucia Prezioso, MD PhD, Sabrina Bonomini, MSc, Noga Or Geva, PhD, Alessandro Monti, MD, Ilenia Manfra, MD, Chiara Schifano, MSc, Federica Galaverna, MD, Yael Zlotnikov Klionsky, PhD, Yair Reisner, PhD

Blood (2016) 128 (22): 5765.

https://doi.org/10.1182/blood.V128.22.5765.5765

Published: 2016

Journal Articles

HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse

Massimo F. Martelli, Mauro Di Ianni, Loredana Ruggeri, Franca Falzetti, Alessandra Carotti, Adelmo Terenzi, Antonio Pierini, Maria Speranza Massei, Lucia Amico, Elena Urbani, Beatrice Del Papa, Tiziana Zei, Roberta Iacucci Ostini, Debora Cecchini, Rita Tognellini, Yair Reisner, Franco Aversa, Brunangelo Falini, Andrea Velardi

Blood (2014) 124 (4): 638–644.

https://doi.org/10.1182/blood-2014-03-564401

Published: 2014

Journal Articles

“Designed” grafts for HLA-haploidentical stem cell transplantation

Massimo F. Martelli, Mauro Di Ianni, Loredana Ruggeri, Antonio Pierini, Franca Falzetti, Alessandra Carotti, Adelmo Terenzi, Yair Reisner, Franco Aversa, Brunangelo Falini, Andrea Velardi

Blood (2014) 123 (7): 967–973.

https://doi.org/10.1182/blood-2013-10-531764

Published: 2014

Journal Articles

Chimerism Induction Without GVHD Following Low Intensity Conditioning In MHC Disparate Recipients: Combining The Benefit Of Cyclophosphamide Post Transplant With The Tolerogenicity Of Megadose T Cell Depleted HSCT

Esther Bachar-Lustig, PhD, Noga Or-Geva, MSc, Yael Zlotnikov Klionsky, MSc, Yair Reisner, PhD

Blood (2013) 122 (21): 3238.

https://doi.org/10.1182/blood.V122.21.3238.3238

Published: 2013

Journal Articles

Perforin Positive Regulatory DCs In Immune Tolerance: Novel Anti-Inflammatory Players In Metabolic Syndrome

Yael Zlotnikov Klionsky, MSc, Bar Nathansohn, M.Sc, Chava Rosen, MD, Ph.D, Anna Aronovich, Ph.D, Steffen Jung, Ph.D, Elias Shezen, PhD, Oren Yifa, Yair Reisner, PhD

Blood (2013) 122 (21): 784.

https://doi.org/10.1182/blood.V122.21.784.784

Published: 2013

Journal Articles

A novel role for factor VIII and thrombin/PAR1 in regulating hematopoiesis and its interplay with the bone structure

Anna Aronovich, Yaniv Nur, Elias Shezen, Chava Rosen, Yael Zlotnikov Klionsky, Irit Milman, Liran Yarimi, David Hagin, Gidi Rechavi, Uriel Martinowitz, Takashi Nagasawa, Paul S. Frenette, Dalit Tchorsh-Yutsis, Yair Reisner

Blood (2013) 122 (15): 2562–2571.

https://doi.org/10.1182/blood-2012-08-447458

Published: 2013

Journal Articles

A new approach for eradication of residual lymphoma cells by host nonreactive anti–third-party central memory CD8 T cells

Assaf Lask, Eran Ophir, Noga Or-Geva, Adva Cohen-Fredarow, Ran Afik, Yaki Eidelstein, Shlomit Reich-Zeliger, Bar Nathansohn, Matthias Edinger, Robert S. Negrin, David Hagin, Yair Reisner

Blood (2013) 121 (15): 3033–3040.

https://doi.org/10.1182/blood-2012-06-432443

Published: 2013

Includes: Supplemental data

Journal Articles

Murine anti–third-party central-memory CD8 + T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells

Eran Ophir, Noga Or-Geva, Irina Gurevich, Orna Tal, Yaki Eidelstein, Elias Shezen, Raanan Margalit, Assaf Lask, Guy Shakhar, David Hagin, Esther Bachar-Lustig, Shlomit Reich-Zeliger, Andreas Beilhack, Robert Negrin, Yair Reisner

Blood (2013) 121 (7): 1220–1228.

https://doi.org/10.1182/blood-2012-07-441493

Published: 2013

Includes: Multimedia, Supplemental data

Journal Articles

Deletion of cognate CD8 T cells by immature dendritic cells: a novel role for perforin, granzyme A, TREM-1, and TLR7

Lior Zangi, Yael Zlotnikov Klionsky, Liran Yarimi, Esther Bachar-Lustig, Yaki Eidelstein, Elias Shezen, David Hagin, Yumi Ito, Toshiyuki Takai, Shlomit Reich-Zeliger, Assaf Lask, Oren Milstein, Steffen Jung, Vera Shinder, Yair Reisner

Blood (2012) 120 (8): 1647–1657.

https://doi.org/10.1182/blood-2012-02-410803

Published: 2012

Includes: Supplemental data

Journal Articles

Haploidentical hematopoietic transplantation: current status and future perspectives

Yair Reisner, David Hagin, Massimo F. Martelli

Blood (2011) 118 (23): 6006–6017.

https://doi.org/10.1182/blood-2011-07-338822

Published: 2011

Journal Articles

Hematopoietic Size Control: A Novel Role for Factor VIII Via the Thrombin/PAR1 Axis in Regulating the Interplay Between Dynamic Bone Structure and Long Term Survival and Mobilization of Hematopoietic Stem Cells

Anna Aronovich, Yaniv Nur, Chava Rosen, Yael Klionsky, Liran Yarimi, David Hagin, Gideon Rechavi, MD, PhD, Uriel Martinowitz, Dalit Tchorsh–Yutsis, Yair Reisner

Blood (2011) 118 (21): 19.

https://doi.org/10.1182/blood.V118.21.19.19

Published: 2011

Journal Articles

Adoptive Immunotherapy with Tregs and Tcons Ensures Low TRM and a Low Incidence of Post Transplant Leukaemia Relapse After HLA Haploidentical Transplants for Acute Leukemia

Mauro Di Ianni, Franca Falzetti, Alessandra Carotti, Adelmo Terenzi, Loredana Ruggeri, Pierini Antonio, Vincenza de Fazio, Valentina Zoi, Maria Speranza Massei, Yair Reisner, Andrea Velardi, Franco Aversa, Massimo Fabrizio Martelli, MD

Blood (2011) 118 (21): 154.

https://doi.org/10.1182/blood.V118.21.154.154

Published: 2011

NARROW

Overcoming NK Cell-Mediated Allograft Rejection By Anti-3 rd Party Central Memory Veto CD8 T Cells through Down-Regulation of the Activating Receptor DNAM-1 on Alloreactive NK Cells

Allogeneic Veto-CAR CD8 T Cells Enabling Prolonged Graft Survival, Anti-Tumor Specificity, and Low Risk of Graft Versus Host Disease

First in Human Study of Anti-Viral Veto Cells Enabling Successful Engraftment without Severe Gvhd in Non-Myeloablative T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

Towards Safer Allogeneic HSCT in Autoimmunity: Proof of Concept in Diabetes-Prone Mice

Proof of Concept for Repair of Sickle Cell Disease By Non-Myeloablative MHC Disparate T Cell Depleted HSCT Combined with Donor-Derived Veto Cells

High Levels of Hematopoietic Progenitors in the Fetal Lung Enable Induction of Immune Tolerance and Co-Transplantation of Epithelial Progenitors for Repair of Lung Injury Across MHC Barriers

Next Generation Veto Cells for Non-Myeloablative Haploidentical HSCT: Combining Anti-Viral and Graft Facilitating Activity

Towards 'Off-the-Shelf ' Universal Chimeric Antigen Receptor (CAR) T Cells: Mouse Anti-3 rd Party Central Memory CD8 Veto Cells Prolong Functional Engraftment of Allogeneic Genetically Modified T Cells

Transplantation of T Cell Depleted Haploidentical HSCT Following Non-Myeloablative (NMA) Conditioning: Combining the Power of Megadose Transplants with Post Transplant Cyclophosphamide (PTCY)

HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse

“Designed” grafts for HLA-haploidentical stem cell transplantation

Chimerism Induction Without GVHD Following Low Intensity Conditioning In MHC Disparate Recipients: Combining The Benefit Of Cyclophosphamide Post Transplant With The Tolerogenicity Of Megadose T Cell Depleted HSCT

Perforin Positive Regulatory DCs In Immune Tolerance: Novel Anti-Inflammatory Players In Metabolic Syndrome

A novel role for factor VIII and thrombin/PAR1 in regulating hematopoiesis and its interplay with the bone structure

A new approach for eradication of residual lymphoma cells by host nonreactive anti–third-party central memory CD8 T cells

Murine anti–third-party central-memory CD8 + T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells

Deletion of cognate CD8 T cells by immature dendritic cells: a novel role for perforin, granzyme A, TREM-1, and TLR7

Haploidentical hematopoietic transplantation: current status and future perspectives

Hematopoietic Size Control: A Novel Role for Factor VIII Via the Thrombin/PAR1 Axis in Regulating the Interplay Between Dynamic Bone Structure and Long Term Survival and Mobilization of Hematopoietic Stem Cells

Adoptive Immunotherapy with Tregs and Tcons Ensures Low TRM and a Low Incidence of Post Transplant Leukaemia Relapse After HLA Haploidentical Transplants for Acute Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only